De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
Clinical trial NCT05622318 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05622318
- Sponsor
- Medical College of Wisconsin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-29
- Primary completion
- 2026-07-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.